Thrombopoietic agent
Thrombopoietic agents are drugs that induce the growth and maturation of megakaryocytes.[1] Some of them are currently in clinical use: romiplostim,[2] eltrombopag, oprelvekin (a recombinant interleukin 11) and thrombopoietin. Several others are under clinical investigation such as lusutrombopag and avatrombopag.
References
[edit]- ^ Michael Clinton Perry. The Chemotherapy Source Book. Lippincott Williams & Wilkins, 2008 pg. 51
- ^ Romiplostim
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |